Lyra Therapeutics, Inc.
No trades
−19.3148 USD
−28.92 M USD
398.00 K USD
33.51 K
About Lyra Therapeutics, Inc.
Sector
Industry
CEO
Maria Palasis
Website
Headquarters
Watertown
Founded
2005
Identifiers
3
ISIN US55234L2043
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat (ENT) diseases. The firm's proprietary XTreo platform delivers medicines directly to targeted sites. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer on November 21, 2005 and is headquartered in Watertown, MA.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of LYRA is 0.6002 USD — it has increased by 24.93% in the past 24 hours. Watch Lyra Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Lyra Therapeutics, Inc. stocks are traded under the ticker LYRA.
LYRA stock has risen by 7.10% compared to the previous week, the month change is a 7.10% rise, over the last year Lyra Therapeutics, Inc. has showed a −95.97% decrease.
LYRA reached its all-time high on May 1, 2020 with the price of 55,000.0000 USD, and its all-time low was 0.3100 USD and was reached on Mar 17, 2026. View more price dynamics on LYRA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LYRA stock is 24.95% volatile and has beta coefficient of 4.08. Track Lyra Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Lyra Therapeutics, Inc. there?
Today Lyra Therapeutics, Inc. has the market capitalization of 1.07 M, it has decreased by −3.45% over the last week.
Yes, you can track Lyra Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
LYRA earnings for the last quarter are −7.14 USD per share, whereas the estimation was −2.59 USD resulting in a −175.68% surprise. The estimated earnings for the next quarter are −1.36 USD per share. See more details about Lyra Therapeutics, Inc. earnings.
Lyra Therapeutics, Inc. revenue for the last quarter amounts to 200.00 K USD, despite the estimated figure of 440.00 K USD. In the next quarter, revenue is expected to reach 0.00 USD.
LYRA net income for the last quarter is −6.95 M USD, while the quarter before that showed −5.98 M USD of net income which accounts for 0.00% change. Track more Lyra Therapeutics, Inc. financial stats to get the full picture.
No, LYRA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 12, 2026, the company has 27 employees. See our rating of the largest employees — is Lyra Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Lyra Therapeutics, Inc. EBITDA is −29.02 M USD, and current EBITDA margin is −7.31 K%. See more stats in Lyra Therapeutics, Inc. financial statements.
Like other stocks, LYRA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lyra Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Lyra Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Lyra Therapeutics, Inc. stock shows the sell signal. See more of Lyra Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.